Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol for calcium and phosphorus control after pediatric hematopoietic stem cell transplantation
IRCT20141227020448N4Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Calcium metabolism disorders and phosphorus metabolism disorder comparing Calcitriol with Placebo (2 arms). Primary endpoints: Change in serum calcium levels and Change in serum phosphorus levels. Started Aug 2026; status: recruiting.
02
Drugs
calcitriol
03
Conditions
Calcium metabolism disordersphosphorus metabolism disorder
Beyond the preview
Go deeper on IRCT20141227020448N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141227020448N4.